Across molecular subtypes, SLC31A1 expression was highest in triple-negative breast cancer (TNBC) and significantly elevated in non-responders (n = 277) compared with responders (n = 196, P = 0.0021; Figure 2B; Table 2). This evidence concerns the gene SLC31A1 and triple-negative breast carcinoma.